Viking Therapeutics
VKTX
VKTX
156 hedge funds and large institutions have $374M invested in Viking Therapeutics in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 43 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 164 → 156 (-8)
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
18% less capital invested
Capital invested by funds: $454M → $374M (-$80.1M)
Holders
156
Holding in Top 10
1
Calls
$19.5M
Puts
$12.3M
Top Buyers
| 1 | +$19.5M | |
| 2 | +$4.9M | |
| 3 | +$3.97M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.42M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$2.42M |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$8.6M | |
| 3 | -$3.57M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$3.09M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.92M |